BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

88 related articles for article (PubMed ID: 8043911)

  • 1. Flow dependence of factor X activation by tissue factor-factor VIIa.
    Contino PB; Andree HA; Nemerson Y
    J Physiol Pharmacol; 1994 Mar; 45(1):81-90. PubMed ID: 8043911
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Phospholipid regulates the activation of factor X by tissue factor/factor VIIa (TF/VIIa) via substrate and product interactions.
    Hathcock JJ; Rusinova E; Gentry RD; Andree H; Nemerson Y
    Biochemistry; 2005 Jun; 44(22):8187-97. PubMed ID: 15924438
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phospholipid surfaces regulate the delivery of substrate to tissue factor:VIIa and the removal of product.
    Hathcock JJ; Rusinova E; Andree H; Nemerson Y
    Blood Cells Mol Dis; 2006; 36(2):194-8. PubMed ID: 16529959
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The structural basis of function of the TF. VIIa complex in the cellular initiation of coagulation.
    Edgington TS; Dickinson CD; Ruf W
    Thromb Haemost; 1997 Jul; 78(1):401-5. PubMed ID: 9198187
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The influence exerted by a restricted phospholipid microenvironment on the expression of tissue factor activity at the cell plasma membrane surface.
    Kunzelmann-Marche C; Satta N; Toti F; Zhang Y; Nawroth PP; Morrissey JH; Freyssinet JM
    Thromb Haemost; 2000 Feb; 83(2):282-9. PubMed ID: 10739387
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibition of factor X activation at extracellular matrix of fibroblasts during flow conditions: a comparison between tissue factor pathway inhibitor and inactive factor VIIa.
    Valentin S; Reutlingsperger CP; Nordfang O; Lindhout T
    Thromb Haemost; 1995 Dec; 74(6):1478-85. PubMed ID: 8772224
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Kinetics of human factor VII activation.
    Butenas S; Mann KG
    Biochemistry; 1996 Feb; 35(6):1904-10. PubMed ID: 8639673
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Studies of the mechanism for enhanced cell surface factor VIIa/tissue factor activation of factor X on fibroblast monolayers after their exposure to N-ethylmaleimide.
    Le DT; Rapaport SI; Rao LV
    Thromb Haemost; 1994 Dec; 72(6):848-55. PubMed ID: 7740453
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Similar molecular interactions of factor VII and factor VIIa with the tissue factor region that allosterically regulates enzyme activity.
    Kelley RF; Yang J; Eigenbrot C; Moran P; Peek M; Lipari MT; Kirchhofer D
    Biochemistry; 2004 Feb; 43(5):1223-9. PubMed ID: 14756558
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Factor VIIa/tissue factor-catalyzed activation of factors IX and X on a cell surface and in suspension: a kinetic study.
    Rao LV; Robinson T; Hoang AD
    Thromb Haemost; 1992 Jun; 67(6):654-9. PubMed ID: 1509405
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A numerical analysis of factor X activation in the presence of tissue factor--factor VIIa complex in a flow reactor.
    Gir S; Slack SM; Turitto VT
    Ann Biomed Eng; 1996; 24(3):394-9. PubMed ID: 8734060
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of catalytic cleft and exosite residues of factor VIIa for complex formation with tissue factor pathway inhibitor.
    Iakhiaev A; Ruf W; Rao LV
    Thromb Haemost; 2001 Mar; 85(3):458-63. PubMed ID: 11307815
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The effects of shear rate on the enzymatic activity of the tissue factor-factor VIIa complex.
    Gemmell CH; Nemerson Y; Turitto V
    Microvasc Res; 1990 Nov; 40(3):327-40. PubMed ID: 2084499
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Selective attenuation of the extrinsic limb of the tissue factor-driven coagulation protease cascade by occupancy of a novel peptidyl docking site on tissue factor.
    Huang H; Norledge BV; Liu C; Olson AJ; Edgington TS
    Biochemistry; 2003 Sep; 42(36):10619-26. PubMed ID: 12962485
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Structure of extracellular tissue factor complexed with factor VIIa inhibited with a BPTI mutant.
    Zhang E; St Charles R; Tulinsky A
    J Mol Biol; 1999 Feb; 285(5):2089-104. PubMed ID: 9925787
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Kinetics of the inhibition of tissue factor-factor VIIa by tissue factor pathway inhibitor.
    Lindhout T; Franssen J; Willems G
    Thromb Haemost; 1995 Sep; 74(3):910-5. PubMed ID: 8571320
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The effects of activated factor VII in a cell-based model for tissue factor-initiated coagulation.
    Kjalke M; Monroe DM; Hoffman M; Oliver JA; Ezban M; Hedner U; Roberts HR
    Blood Coagul Fibrinolysis; 1998 Mar; 9 Suppl 1():S21-5. PubMed ID: 9819025
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Importance of factor VIIa Gla-domain residue Arg-36 for recognition of the macromolecular substrate factor X Gla-domain.
    Ruf W; Shobe J; Rao SM; Dickinson CD; Olson A; Edgington TS
    Biochemistry; 1999 Feb; 38(7):1957-66. PubMed ID: 10026279
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Transport rate limited catalysis on macroscopic surfaces: the activation of factor X in a continuous flow enzyme reactor.
    Andree HA; Contino PB; Repke D; Gentry R; Nemerson Y
    Biochemistry; 1994 Apr; 33(14):4368-74. PubMed ID: 8155655
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Protein disulfide isomerase has no stimulatory chaperone effect on factor X activation by factor VIIa-soluble tissue factor.
    Persson E
    Thromb Res; 2008; 123(1):171-6. PubMed ID: 18550154
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.